News
MMSI
72.03
+1.47%
1.04
Merit Medical Price Target Maintained With a $98.00/Share by Barrington Research
Dow Jones · 3d ago
Merit Medical Is Maintained at Outperform by Barrington Research
Dow Jones · 3d ago
Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $98 Price Target
Benzinga · 3d ago
Outperform Rating Maintained for Merit Medical Systems Amid Strong Growth and Profitability Projections
TipRanks · 3d ago
Merit Medical Systems, Inc. (NASDAQ:MMSI) Not Lagging Market On Growth Or Pricing
Merit Medical Systems, Inc.'s price-to-earnings ratio is 44.2x compared to the market. The company is expected to deliver strong earnings growth over the next three years. Merit Medical Systems has a high P/E ratio compared to most companies in the U.S. With similar growth rates. It may be trading at a high price because investors believe the company will perform better than most.
Simply Wall St · 3d ago
Weekly Report: what happened at MMSI last week (0408-0412)?
Weekly Report · 4d ago
Merit Medical Initiated at Buy by CL King
Dow Jones · 04/11 18:35
Merit Medical Price Target Announced at $88.00/Share by CL King
Dow Jones · 04/11 18:35
CL King Initiates Coverage On Merit Medical Systems with Buy Rating, Announces Price Target of $88
Benzinga · 04/11 18:25
Decoding 7 Analyst Evaluations For Merit Medical Systems
Merrit Medical Systems Inc is a medical equipment company that develops and manufactures products. The company has an average 12-month price target of $92.71. 7 analysts have shared their evaluations of Merit Medical systems in the last three months. The firm has a positive revenue growth rate of 10.6%. The company's return on equity surpasses industry standards.
Benzinga · 04/11 15:01
Merit Medical Price Target Maintained With a $88.00/Share by Needham
Dow Jones · 04/11 08:46
Needham Reiterates Buy on Merit Medical Systems, Maintains $88 Price Target
Benzinga · 04/11 08:36
Merit Medical Systems (MMSI) Poised for Growth: Buy Rating Affirmed on Strategic Initiatives and New Product Launch
TipRanks · 04/10 19:25
Here's Why You Should Retain Merit Medical (MMSI) Stock for Now
NASDAQ · 04/10 13:33
Weekly Report: what happened at MMSI last week (0401-0405)?
Weekly Report · 04/08 09:25
BDX vs. MMSI: Which Stock Is the Better Value Option?
NASDAQ · 04/03 15:40
When Should You Buy Merit Medical Systems, Inc. (NASDAQ:MMSI)?
Merit Medical Systems, Inc. (NASDAQ:MMSI) is currently trading at a price of US$75.13. The mid-cap company is expected to grow earnings by 69% over the next few years. The company's share price is trading around the average of its industry peers. Is MMSI currently undervalued? We take a look at the company's outlook and future growth.
Simply Wall St · 04/02 17:59
Notable Two Hundred Day Moving Average Cross - MMSI
NASDAQ · 04/02 16:08
Weekly Report: what happened at MMSI last week (0325-0329)?
Weekly Report · 04/01 09:24
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
NASDAQ · 03/26 10:20
More
Webull provides a variety of real-time MMSI stock news. You can receive the latest news about Merit Med Sys Inc through multiple platforms. This information may help you make smarter investment decisions.
About MMSI
Merit Medical Systems, Inc. designs, develops, manufactures, markets and sells medical products for interventional and diagnostic procedures. The Company is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions and original equipment manufacturer. Within these product categories, it sells a variety of products, including cardiology and radiology devices, as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care and others. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.